Treatment Advancements in Atopic Dermatitis With JAK Inhibitors: Updates for Pharmacists | PTCE Pharmacy Connect

The educational objectives are:

• Review the pathophysiology of atopic dermatitis (AD) as well as the efficacy and safety data for topical JAK inhibitors that are approved and in development

• Discuss the role of pharmacists as a part of the care team for patients with AD as well as the key counseling points and monitoring parameters

 

Faculty: Dennis Williams

Moderator: Jamie McConaha